Ishida, Julie H <br/><br/>
Phase 1 Randomized, Double-Blind, Placebo-Controlled Study of RG7667, an Anticytomegalovirus Combination Monoclonal Antibody Therapy, in Healthy Adults.  [electronic resource] 

 -  Antimicrobial agents and chemotherapy  Aug 2015 
 - 4919-29 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1098-6596 
<br/><br/><label>Standard No.: </label>10.1128/AAC.00523-15  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antibodies, Monoclonal--pharmacokinetics<br/>Antiviral Agents--pharmacokinetics<br/>Cytomegalovirus--drug effects<br/>Dose-Response Relationship, Drug<br/>Double-Blind Method<br/>Drug Therapy, Combination--methods<br/>Female<br/>Half-Life<br/>Healthy Volunteers<br/>Humans<br/>Male